{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:04:52Z","timestamp":1792713892650,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["T32 DC00038"],"award-info":[{"award-number":["T32 DC00038"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["K08DC010419"],"award-info":[{"award-number":["K08DC010419"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009152","name":"Bertarelli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14-1-0091"],"award-info":[{"award-number":["W81XWH-14-1-0091"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.trsl.2014.12.007","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T16:55:35Z","timestamp":1420649735000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas"],"prefix":"10.1016","volume":"166","author":[{"given":"Sonam","family":"Dilwali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyan-Yuan","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas D.","family":"Landegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina M.","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2014.12.007_bib1","first-page":"347","article-title":"Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS","volume":"36","author":"Mahaley","year":"1990","journal-title":"Clin Neurosurg"},{"key":"10.1016\/j.trsl.2014.12.007_bib2","first-page":"1","article-title":"Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation","volume":"40","author":"Matthies","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.trsl.2014.12.007_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0194599813512106","article-title":"Complications of surgery for sporadic vestibular schwannoma","volume":"150","author":"Mahboubi","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.trsl.2014.12.007_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3171\/2009.10.JNS091203","article-title":"Beyond audiofacial morbidity after vestibular schwannoma surgery","volume":"114","author":"Sughrue","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.trsl.2014.12.007_bib5","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/j.ijrobp.2011.04.066","article-title":"Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience","volume":"81","author":"Collen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.trsl.2014.12.007_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0030-1253576","article-title":"Malignant transformation of acoustic neuroma\/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery","volume":"20","author":"Demetriades","year":"2010","journal-title":"Skull Base"},{"key":"10.1016\/j.trsl.2014.12.007_bib7","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2012.6.FOCUS12144","article-title":"An update on unilateral sporadic small vestibular schwannoma","volume":"33","author":"Thakur","year":"2012","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.trsl.2014.12.007_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1227\/NEU.0b013e318208f5c7","article-title":"Cyclooxygenase-2 supports tumor proliferation in vestibular schwannomas","volume":"68","author":"Hong","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.trsl.2014.12.007_bib9","doi-asserted-by":"crossref","first-page":"215158","DOI":"10.1155\/2010\/215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies","volume":"2010","author":"Sobolewski","year":"2010","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.trsl.2014.12.007_bib10","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","author":"Goodman","year":"1996"},{"key":"10.1016\/j.trsl.2014.12.007_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11912-013-0351-3","article-title":"Role of aspirin in cancer prevention","volume":"15","author":"Thorat","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.trsl.2014.12.007_bib12","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V93.7.2386","article-title":"Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines","volume":"93","author":"Klampfer","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2014.12.007_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/gut.49.6.783","article-title":"Low dose balsalazide (1.5\u00a0g twice daily) and mesalazine (0.5\u00a0g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0\u00a0g twice daily) was superior in preventing relapses","volume":"49","author":"Kruis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2014.12.007_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2036.2007.03455.x","article-title":"Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission","volume":"26","author":"Sandborn","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.trsl.2014.12.007_bib15","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.3390\/ijms140917972","article-title":"Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer","volume":"14","author":"Stolfi","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2014.12.007_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11010-013-1620-z","article-title":"Protection against peroxynitrite-induced DNA damage by mesalamine: implications for anti-inflammation and anti-cancer activity","volume":"378","author":"Graham","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.trsl.2014.12.007_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2014.05.006","article-title":"Primary culture of human Schwann and schwannoma cells: improved and simplified protocol","volume":"315","author":"Dilwali","year":"2014","journal-title":"Hear Res"},{"key":"10.1016\/j.trsl.2014.12.007_bib18","doi-asserted-by":"crossref","first-page":"e48208","DOI":"10.1371\/journal.pone.0048208","article-title":"Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors","volume":"7","author":"Pathi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2014.12.007_bib19","first-page":"1865","article-title":"Potent reactive oxygen species-JNK-p38 activation by sodium salicylate potentiates death of primary effusion lymphoma cells","volume":"34","author":"Vaeteewoottacharn","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.trsl.2014.12.007_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MAO.0000000000000189","article-title":"Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in\u00a0vivo","volume":"35","author":"Kandathil","year":"2014","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.trsl.2014.12.007_bib21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","article-title":"Aspirin, salicylates, and cancer","volume":"373","author":"Elwood","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2014.12.007_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5694\/j.1326-5377.2011.tb04201.x","article-title":"Salicylate intoxication from teething gel in infancy","volume":"194","author":"Williams","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.trsl.2014.12.007_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.1780140412","article-title":"Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis","volume":"14","author":"Paulus","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2014.12.007_bib24","first-page":"869","article-title":"Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function","volume":"103","author":"Cerletti","year":"1984","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2014.12.007_bib25","first-page":"146","article-title":"Tinnitus as a measure of salicylate toxicity in the overdose setting","volume":"9","author":"Samlan","year":"2008","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.trsl.2014.12.007_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM196509092731104","article-title":"Salicylate ototoxicity: a clinical study","volume":"273","author":"Myers","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2014.12.007_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0753-3322(89)90140-6","article-title":"Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid","volume":"43","author":"Bannwarth","year":"1989","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.trsl.2014.12.007_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/ctrv.2000.0194","article-title":"The blood-brain barrier and oncology: new insights into function and modulation","volume":"26","author":"Bart","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.trsl.2014.12.007_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1073\/pnas.95.2.681","article-title":"Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis","volume":"95","author":"Chan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2014.12.007_bib30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.trsl.2014.12.007_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2014.12.007_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2014.12.007_bib33","doi-asserted-by":"crossref","first-page":"27613","DOI":"10.1074\/jbc.M201119200","article-title":"Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line","volume":"277","author":"Arico","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2014.12.007_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/j.trsl.2014.12.007_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.1107107","article-title":"PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation","volume":"308","author":"Lee","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.trsl.2014.12.007_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MAO.0b013e318206fc3d","article-title":"EGF and bFGF promote invasion that is modulated by PI3\/Akt kinase and Erk in vestibular schwannoma","volume":"32","author":"Blair","year":"2011","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.trsl.2014.12.007_bib37","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.ejca.2009.03.013","article-title":"Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells","volume":"45","author":"Lee","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T19:13:06Z","timestamp":1598641986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152441500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S193152441500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2014.12.007","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}